New Drugs
Tetrabenazine
$10.00
Universal Activity Number: 407-000-10-016-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 06/01/2010
Expiration date: 06/01/2013
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 06/01/2010
Expiration date: 06/01/2013
Article title:
view more on 407-000-10-016-H01-P
Role of Tetrabenazine for Huntington's Disease–Associated Chorea
Eltrombopag
$10.00
Universal Activity Number: 407-000-10-019-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 06/01/2010
Expiration date: 06/01/2013
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 06/01/2010
Expiration date: 06/01/2013
Article title:
view more on 407-000-10-019-H01-P
Eltrombopag: A Novel Oral Thrombopoietin Receptor Agonist
Rivaroxaban for Thromboprophylaxis
$10.00
Universal Activity Number: 407-000-10-017-H01-P
CEUs 1.5
Audience: Pharmacist
Activity Type: Application-based
Issued date: 06/01/2010
Expiration date: 06/01/2013
CEUs 1.5
Audience: Pharmacist
Activity Type: Application-based
Issued date: 06/01/2010
Expiration date: 06/01/2013
Article title:
view more on 407-000-10-017-H01-P
Rivaroxaban for Thromboprophylaxis in Patients Undergoing Major Orthopedic Surgery
Pazopanib in Renal Cell Carcinoma
$10.00
Universal Activity Number: 407-000-10-018-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 06/01/2010
Expiration date: 06/01/2013
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 06/01/2010
Expiration date: 06/01/2013
Article title:
view more on 407-000-10-018-H01-P
Pazopanib: An Oral Multitargeted Tyrosine Kinase Inhibitor for Use in Renal Cell Carcinoma
Saxagliptin for Type 2 Diabetes
$10.00
Universal Activity Number: 407-000-10-020-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 06/01/2010
Expiration date: 06/01/2013
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 06/01/2010
Expiration date: 06/01/2013
Article title:
view more on 407-000-10-020-H01-P
Saxagliptin: A New Dipeptidyl Peptidase 4 Inhibitor for Type 2 Diabetes



